Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rotigotine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117965476A details a novel reductive aminase mutant for high-purity rotigotine intermediate synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102010400A details a novel chiral resolution route for Rotigotine intermediates, offering high purity and streamlined manufacturing for reliable pharmaceutical supply chains.
Novel chiral induction method for Rotigotine intermediate. Reduces cost and improves scalability for pharmaceutical manufacturing supply chains globally.
Patent CN101717392A details a novel rotigotine synthesis using chiral phosphoric acid resolution, offering high optical purity and cost reduction in API manufacturing.